The expression of antioxidant enzymes, including catalase, superoxide dismutase I (SOD1), and superoxide dismutase II (SOD2), in the aorta was not significantly affected by obesity and pioglitazone treatment (Fig. 2c). This evidence concerns the gene SOD2 and obesity due to melanocortin 4 receptor deficiency.